Intensified oxidative and nitrosative stress following combined ALA-based photodynamic therapy and local hyperthermia in rat tumors

International Journal of Cancer

Volumn 107, Issue 6, 2003, Pages 941-948

  Frank, Juergen ^a   Lambert, Christine ^a   Biesalski, Hans Konrad ^a   Thews, Oliver ^b   Vaupel, Peter ^b   Kelleher, Debra K ^b  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

ALA; Apoptosis; Heat shock proteins; Hyperthermia; Oxidative stress; Peroxynitrite; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; CASPASE; DNA FRAGMENT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEAT SHOCK PROTEIN 70; NITROSAMINE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERTHERMIC THERAPY; MALE; NICK END LABELING; NITROSATION; NONHUMAN; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOMA;

AMINOLEVULINIC ACID; ANIMALS; APOPTOSIS; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEAT-SHOCK PROTEINS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HSP70 HEAT-SHOCK PROTEINS; LIGHT; MALE; NITROSATION; OXYGENASES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SARCOMA;

EID: 0242677811     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11507     Document Type: Article

References (63)

1. Dougherty TJ. An update on photodynamic therapy applications. J Clin Laser Med Surg 2002;20:3-7.
2. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 2000;1:212-9.
3. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976;36:2326-9.
4. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin Pharmacother 2001;2:917-27.
5. Ades IZ. Heme production in animal tissues: the regulation of biogenesis of delta-aminolevulinate synthase. Int J Biochem 1990;22:565-78.
6. Gibson SL, Cupriks DJ, Havens JJ, Nguyen ML, Hilf R. A regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolaevulinic acid (delta-ALA)-induced photosensitization? Br J Cancer 1998;77:235-43.
7. el Sharabasy MM, el Waseef AM, Hafez MM, Salim SA. Porphyrin metabolism in some malignant diseases. Br J Cancer 1992;65:409-12.
8. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997;79:2282-308.
9. Kelleher DK, Bastian J, Thews O, Vaupel P. Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours. Br J Cancer, 2003;89:405-11.
10. Streffer C. Molecular and cellular mechanisms of hyperthermia. In: Seegenschmiedt MH. Fessenden P. Vernon CC. Thermoradiotherapy and thermochemotherapy. Berlin: Springer-Verlag, 1995. 47-74.
11. Wong R, Dewey WC. Effect of hyperthermia on DNA synthesis. In: Anghilieri LJ, Robert J. Hyperthermia in cancer treatment, vol. 1. Boston: Martinum Nijhoff, 1986. 79-92.
12. Wong RS, Dewey WC. Molecular studies on the hyperthermic inhibition of DNA synthesis in Chinese hamster ovary cells. Radiat Res 1982;92:370-95.
13. Leyko W, Bartosz G. Membrane effects of ionizing radiation and hyperthermia. Int J Radiat Biol 1986;49:743-70.
14. Kelleher DK, Engel T, Vaupel PW. Changes in microregional perfusion, oxygenation. ATP and lactate distribution in subcutaneous rat tumours upon water-filtered IR-A hyperthermia. Int J Hyperthermia 1995;11:241-55.
15. Frank J, Kelleher DK, Pompella A, Thews O, Biesalski HK, Vaupel P. Enhancement of oxidative cell injury and antitumor effects of localized 44°C hyperthermia upon combination with respiratory hyperoxia and xanthine oxidase. Cancer Res 1998;58:2693-8.
16. Kelty CK, Brown NJ, Reed MWR, Ackroyd R. The use of 5-aminolaevulinic acid as a photosensitizer in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci 2002;1:158-68.
17. Chakrabarti P, Orihuela E, Egger N, Neal DE Jr, Gangula R, Adesokun A, Motamedi M. Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines: implication for photodynamic therapy of prostate cancer. Prostate 1998;36:211-8.
18. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J. United Kingdom co-ordinating committee on cancer research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia, 2nd ed. Br J Cancer 1998;77:1-10.
19. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
21. Kuhn KS, Krasselt AI, Furst P. Glutathione and glutathione metabolites in small tissue samples and mucosal biopsies. Clin Chem 2000;46:1003-5.
22. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-37.
23. Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998;25:434-56.
24. Demiryurek AT, Cakici I, Kanzik I. Peroxynitrite: a putative cytotoxin. Pharmacol Toxicol 1998;82:113-7.
25. Riobo NA, Clementi E, Melani M, Boveris A, Cadenas E, Moncada S. Poderoso JJ. Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem J 2001;359:139-45.
26. Brown GC. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999;1411:351-69.
27. Sonveaux P, Brouet A, Havaux X, Gregoire V, Dessy C, Balligand JL, Feron O. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res 2003;63:1012-9.
28. Hirakawa M, Oike M, Masuda K, Ito Y. Tumor cell apoptosis by irradiation-induced nitric oxide production in vascular endothelium. Cancer Res 2002;62:1450-1457.
29. Fuchs J, Weber S, Kaufmann R. Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy. Free Radic Biol Med 2000;28:537-48.
30. Korbelik M, Parkins CS, Shibuya H, Cecic I, Stratford MR, Chaplin DJ. Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br J Cancer 2000;82:1835-43.
31. Henderson BW, Sitnik-Busch TM, Vaughan LA. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent. Photochem Photobiol 1999;70:64-71.
32. Joshi MS, Ponthier JL, Lancaster JR. Cellular antioxidant and prooxidant actions of nitric oxide. Free Radic Biol Med 1999;27:1357-66.
33. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999;31:273-300.
34. Drake J, Kanski J, Varadarajan S, Tsoras M, Butterfield DA. Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J Neurosci Res 2002;68:776-84.
35. Miller AC, Henderson BW. The influence of cellular glutathione content on cell survival following photodynamic treatment in vitro. Radiat Res 1986;107:83-94.
36. Jiang F, Lilge L, Belcuig M, Singh G, Grenier J, Li Y, Chopp M. Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain. Lasers Surg Med 1998;23:161-6.
37. Freeman ML, Malcolm AW, Meredith MJ. Decreased intracellular glutathione concentration and increased hyperthermic cytotoxicity in an acid environment. Cancer Res 1985;45:504-8.
38. Freeman ML, Malcolm AW, Meredith MJ. Role of glutathione in cell survival after hyperthermic treatment of Chinese hamster ovary cells. Cancer Res 1985;45:6308-13.
39. Jones EL, Douple EB. The effect of in vivo GSH depletion on thermosensitivity, radiosensitivity and thermal radiosensitization. Int J Hyperthermia 1990;6:951-5.
40. Anderstam B, Harms-Ringdahl M. Increased antineoplastic activity of combined hyperthermic and bleomycin treatments in an adenocarcinoma after glutathione depletion in vivo. Int J Hyperthermia 1988;4:297-306.
41. Coppola S, Ghibelli L. GSH extrusion and the mitochondrial pathway of apoptotic signalling. Biochem Soc Trans 2000;28:56-61.
42. Boyd CS, Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol Chem 2002;383:411-23.
43. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999;68:383-424.
44. Morgan J, Oseroff AR. Mitochondria-based photodynamic anti-cancer therapy. Adv Drug Deliv Rev 2001;49:71-86.
45. Houge G, Robaye B, Eikhom TS, Golstein J, Mellgren G, Gjertsen BT, Lanotte M, Doskeland SO. Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol Cell Biol 1995;15:2051-62.
46. Bellmann K, Jaattela M, Wissing D, Burkart V, Kolb H. Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett 1996;391:185-8.
47. Bishop A, Marquis JC, Cashman NR, Demple B. Adaptive resistance to nitric oxide in motor neurons. Free Radic Biol Med 1999;26:978-86.
48. Vile GF, Basu-Modak S, Waltner C, Tyrrell RM. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci USA 1994;91:2607-10.
49. Ryter SW, Otterbein LE, Morse D, Choi AM. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 2002;234:249-63.
50. Lee PJ, Alam J, Wiegand GW, Choi AM. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci USA 1996;93:10393-8.
51. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997;94:10925-30.
52. Gomer CJ, Ryter SW, Ferrario A, Rucker N, Wong S, Fisher AM. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Res 1996;56:2355-60.
53. Ewing JF, Raju VS, Maines MD. Induction of heart heme oxygenase-1 (HSP32) by hyperthermia: possible role in stress-mediated elevation of cyclic 3′:5′-guanosine monophosphate. J Pharmacol Exp Ther 1994;271:408-14.
54. Vaupel P. Hypoxia in neoplastic tissue. Microvasc Res 1977;13:399-408.
55. Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, Shibahara S, Ogawa M, Maeda H. Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer 1999;80:1945-54.
56. Kregel KC. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 2002;92:2177-86.
57. Xue LY, Agarwal ML, Varnes ME. Elevation of GRP-78 and loss of HSP-70 following photodynamic treatment of V79 cells: sensitization by nigericin. Photochem Photobiol 1995;62:135-43.
58. Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 1998;79:468-75.
59. Barnes JA, Dix DJ, Collins BW, Luft C, Allen JW. Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress Chaperones 2001;6:316-25.
60. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2000;2:476-83.
61. Li CY, Lee JS, Ko YG, Kim JI, Seo JS. Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation. J Biol Chem 2000;275:25665-71.
62. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, Zamzami N, Mak T, Jaattela M, Penninger JM, Garrido C, Kroemer G. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 2001;3:839-43.
63. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jaattela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 2000;97:7871-6.